/Companies

Cytocentrics

San Antonio, US · Founded 2014 · Delaware corporation · 1 known investors

Find your way into Cytocentrics

Sign up to see every warm intro you have to Cytocentrics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytocentrics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JR
James R. GarvinChief Executive Officer, President, Secretary and Treasurer

Investors · 1

Reported raises · per SEC filings

Form D private placements

$17.4M disclosed across 2 of 3 rounds · 2015–2018

▶$1.5MraisedMar 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan DeanDirector
  • Paul CastellaDirector
  • James R. GarvinExecutive Officer, Director
  • Ian ClementsDirector
Offering amount
$1.5M
Amount sold
$1.5M
Sales commissions
$90K
Proceeds to insiders
$250K
Placement agents
Divine Capital Markets
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.8MraisedJan 2018 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ian ClementsDirector
  • James R. GarvinExecutive Officer, Director
  • Alan DeanDirector
  • Paul CastellaDirector
Offering amount
$21.8M
Amount sold
$15.8M
Sales commissions
$137.5K
Placement agents
Divine Capital Markets LLC
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedMar 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James R. GarvinExecutive Officer, Director
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Cytocentrics's investors?
Cytocentrics's investors include Targeted Technology Funds.
How much funding has Cytocentrics raised?
Cytocentrics has disclosed $17.4M raised across 2 of its 3 known rounds.
Where is Cytocentrics headquartered?
Cytocentrics is headquartered in San Antonio, US.